1
0
0
(1 - 43 from 129
)
Raymund Breu at Novartis Corporation (USA) Contact Details |...
leadferret.com
Raymund Breu at Novartis Corporation (USA) Contact Details - find the Job Title, Phone#, Email Address, Social Profiles (Including Facebook, LinkedIn and ...
Raymund Breu Ph.D. - Executive Bio, Compensation …
people.equilar.com
View Raymund Breu Ph.D., Former Chief Financial Officer at Novartis AG, executive profile on Equilar Atlas to see current salary at Novartis AG and compensation ...
Raymund Breu Ph.D. - Executive Bio, Work History, and Contacts -...
people.equilar.com
View the executive profile of Raymund Breu Ph.D., Former Chief Financial Officer at Novartis AG, on Equilar BoardEdge to see current and past work history and...
Novartis Q2 2007 Earnings Call Transcript | Seeking Alpha
seekingalpha.com
TRANSCRIPT SPONSOR Novartis AG (NYSE:NVS) Q2 2007 Earnings Call July 17, 2007 8:00 am ET Executives Raymund Breu - CFO Richard Jarvis - IR Thomas Ebeling - …
Raymund Breu, Novartis
connection.ebscohost.com
EBSCOhost serves thousands of libraries with premium essays, articles and other content including Raymund Breu, Novartis. Get access to over 12 million other ...
Valuation + Dcf Model Download - Mckinsey & Company Inc. ; Koller ...
www.hoepli.it
Dr. Raymund Breu, retired Chief Financial Officer, Novartis AG. "A 'how–to' guide for corporate executives who want to get at the unrealized shareholder values trapped in public companies." ?New York Times. "The book's clarity and comprehensive coverage make it one of the best practitioners' guides to valuation." ?
PRAISE FOR THE PREVIOUS EDITIONS OF VALUATION
leseprobe.buch.de
—Dr. Raymund Breu, former chief fi nancial offi cer, Novartis AG “aluationV gets to the heart of how to measure and manage value in a company. Whether you
Hexal-Kapitalismus: der Aufstieg der Brüder Strüngmann
books.google.pl
Bald darauf folgte ein kurzes Treffen am Flughafen, zusammen mit dem Finanzchef von Novartis, Raymund Breu. Der Schweizer setzte für die Due Diligence zwei Wochen an. Das ist die Wertermittlung eines Unternehmens durch externe Experten und damit eine unverzichtbare Grundlage für Verkaufsgespräche.
The Fundamentals of Business Writing:: At Corporations and Governments
books.google.pl
Respectfully submitted, Novartis AG [sf Raymund Breu [sf Urs Baerlocher Raymund Breu Urs Baerlocher Chief Financial Officer Head of Group Legal and Tax Novartis Group Novartis Group INTEL CORPORATION IO-K REPORT 2005 Acquisitions and Strategic Investments During 2005, we completed three acquisitions ...
FINANCE FACTORIES The road to CFO CAREER PATHS
www.cfo.com
Raymund Breu Novartis Christian Mulliez L’Oreal Robert Castaigne Total Reinhard Ortner Erste Bank Rob Frohn Akzo Nobel Leif ...
Novartis Group Annual Report 2010
www.annualreports.com
Raymund Breu as Chief Financial Offi cer. 6 NOVARTIS GROUP ANNUAL REPORT 2010. Daniel Vasella, M.D. 7 DEAR SHAREHOLDER I am pleased to …
Information - Nobel Biocare
www.nobelbiocare.com
(1945) Swiss. Raymund Breu, PhD, was CFO of Novartis AG and a member of its Execu- tive Committee from 1996 until 2009. Dr Breu joined the Treasury Department of the. Sandoz Group in 1975. In 1982, he became Head of Finance for Sandoz affiliates in the. United Kingdom. In 1985, he was appointed Chief Financial ...
Novartis -20-F- 2009
www.novartis.com
Raymund Breu, Ph.D., is Chief Financial Officer of Novartis AG since 1996. He is a member of the. Executive Committee of Novartis. Mr. Breu joined the Treasury Department of the Sandoz Group in. 1975. In 1982, he became Head of Finance for the Sandoz affiliates in the United Kingdom. In 1985, he.
bol.com: Valuation - Bol.com
It is required reading for all executives."ùProfessor Benjamin C. Esty, Harvard Business School, author of Modern Project Finance: A Casebook "The bible in its field. Anyone wanting to understand what drives corporate value should read this latest edition."ùDr. Raymund Breu, former chief financial officer, Novartis AG
Chiron's Sean Lance to Succeed Bill Rutter as Chairman of the Board;...
www.thefreelibrary.com
Free Online Library: Chiron's Sean Lance to Succeed Bill Rutter as Chairman of the Board; Raymond Breu of Novartis Elected to Board. by
Ein Rekordgewinn zum Abschied: Neuer Chef für Novartis - n-tv.de
www.n-tv.de
Neuer Finanzchef wird Jon Symonds, der ab Februar auf Raymund Breu folgt, der am 31. März altersbedingt ausscheidet. Die größte Geschäftssparte Pharma leitet künftig David Epstein, der bisher für die Krebsmittel verantwortlich war. Chief Operating Officer Jörg Reinhardt, der als Vasella-Nachfolger ...
Novartis: Goldman-Sachs-Banker wird Finanzchef - manager magazin
www.manager-magazin.de
Jonathan Symonds wird beim Schweizer Pharmakonzern Novartis Nachfolger des langjährigen Finanzchefs Raymund Breu. Der 50-Jährige kommt von Goldman Sachs, wo er derzeit Managing Director des Investment Banking ist. Breu wird Ende März kommenden Jahres in Pension gehen.
Nach Eugen Haltiners Rücktritt: Finma braucht neuen Präsidenten - Blick
www.blick.ch
Nummer Drei: Raymund Breu (65). SonntagsBlick-Rating: 3 von 5 Punkten Karriere: Trat im Januar als Finanzchef von Novartis zurück. Seit 2003 sitzt er im Verwaltungsrat des Rückversicherers Swiss Re. Profil: Der Mathematiker ist international bestens vernetzt. Eignung: Kennt nicht nur alle Tricks der ...
NZZ: «Wir brauchen dreimal mehr Kapital» | NZZ
Wirtschaft: Urs Rohner, Vize-Präs. des Verwaltungsrats der Credit Suisse Group Ulrich Körner, Chief Operating Officer, Konzernleitungsmitglied der UBS Raymund Breu, ehem. Finanzchef von Novartis Hermann Geiger, Chefjurist und Konzernleitungsmitglied der Swiss Re Dieter Wemmer, Finanzchef der ...
Google Blogs: New Novartis CEO Joe Jimenez has a background in consumer goods ...
26.01.2010 He will succeed Raymund Breu on February 1. Activist investor group Ethos welcomed Novartis's decision to give shareholders a vote on executive pay, a hot topic during tight economic times and particularly for the drugmaker as Vasella's ...
Novartis earnings shine - Aug. 21, 2000
money.cnn.com
Europe's third-biggest drug maker, Novartis AG, said Monday first-half profit jumped 30 percent, above expectations, helped by rising demand for hypertension,...
Novartis – People (2009)
horrorhasaface.wordpress.com
28.03.2010 by horrorhasaface Raymund Breu, Ph.D. - Chief Financial Officer and Member of the Executive Committee since 1996. - Joined the Treasury Department of the Sandoz Group (1975); Head of Finance for the Sandoz affiliates in the UK (1982); Chief Financial ...
Valuation - Measuring and Managing the Value of Companies, 5th...
bbs.pinggu.org
—Dr. Raymund Breu, former chief financial officer, Novartis AG "Valuation gets to the heart of how to measure and manage value in a company.
Raymund Breu – Milliarden-Jongleur | albatros-navigation.ch
www.albatros-navigation.ch
Novartis-Finanzchef Raymund Breu würde es begrüssen, wenn Konkurrent Roche als Kreuzbeteiligung ein Novartis-Aktienpaket übernähme. –: Herr Breu, mit wie viel Geld jonglieren Sie im Laufe eines Jahres? Raymund Breu: Wir investieren rund 40 Milliarden im Finanzmarkt – 23 Milliarden von der Firma und 17 ...
A New Star for Novartis? - David Mendosa: Helping …
www.mendosa.com
Each of these drugs could generate peak annual sales of $1 billion or more, Novartis Chief Financial Officer Raymund Breu declared at a news conference last year.
CL10 - IASCF Rev Const - SWISSHoldings - EFRAG
www.efrag.org
Dr. Raymund Breu. Chair, Novartis AG. Dr. Peter Baumgartner. Chairman Executive Committee. cc SH Board. Appendix. Comments on the outcome of the first phase of the Constitution Review. It is unfortunate that the Trustees did not provide any feedback statement on the comments they have received in their first-phase ...
Changes in Presidium of the Admission Board - SIX
www.six-group.com
standing member Raymund Breu, CFO and member of the Executive Committee at Novartis, Basel. In addition, other new members of the Admission Board were won in the persons of David Frick, Nestlé;. Christian Gell, Credit Suisse; Michel Juvet, Banque Bordier & Cie; Martin Sieg Castagnola, Zurich.
Chiron Vaccines - Powerbase
powerbase.info
Howard Pien - Chief Executive Officer and Chairman of the Board, Chiron Corporation · Raymund Breu, Ph.D. - Chief Financial Officer, Member of the Executive Committee, Novartis AG; Vaughn D. Bryson - Retired President and Chief Executive Officer, Eli Lilly and Company; Lewis W. Coleman - Retired ...
Chiron's Sean Lance to Succeed Bill Rutter as Chairman of the Board
quod.lib.umich.edu
... Ph.D. The company also announced that Raymund Breu, Ph.D., Novartis AG's chief financial officer, has been elected to Chiron's board of directors, replacing Alex Krauer, Ph.D., Novartis' former chairman. Setn Lance, who joined Chiron from Glaxo Wellcome plc where he was chief operating officer, will chair the board, ...
Novartis hires ex-Goldman banker - Financial Times
www.ft.com
He will replace Raymund Breu, ... The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Executive Officers and Senior Management for Novartis_AG (NVS)
www.wikinvest.com
Raymund Breu, Ph.D., Swiss, age 62. Raymund Breu graduated from the Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland, with a Ph.D. in mathematics. In 1975, he joined the Treasury Department of the Sandoz Group, and in 1982, became the Head of Finance for the Sandoz affiliates in the UK. In 1985 ...
Financial Training: The CFO University — Chief Learning Officer - CLO ...
www.clomedia.com
At a recent program for finance professionals, speakers included the global head of accounting, divisional CFOs and country CFOs. Finance programs also include an interactive video teleconference with Novartis Chief Financial Officer Raymund Breu. The company continues to refine its finance programs, ...
Justine Varieur Cadet | Cardiovascular Business
www.cardiovascularbusiness.com
May 21, 2009. Jonathan Symonds, currently managing director of investment banking at Goldman Sachs, will join Novartis on Sept. 1 as deputy chief financial officer (CFO) and as CFO designate, reporting to Raymund Breu, who will retire on March 31, 2010. READ MORE >> · Boston Scientific unveils new stent system.
Make a selection - Magnum Photos
pro.magnumphotos.com
Stuart Franklin 2008. SWITZERLAND. Basel. Novartis Campus. Raymund Breu. 2008. LON107504. HR. R. E. Stuart Franklin 2008. SWITZERLAND. Basel. Novartis Campus. Joe Jimenez. 2008. LON107505. HR. R. E. Stuart Franklin 2008. SWITZERLAND. Basel. Novartis Campus. Juergen Brokatzky-Geiger.... LON107507.
Medienmitteilung 05.05.2003 Zulassungsstelle verschärft ...
www.six-swiss-exchange.com
Als Vizepräsident: Dr. Raymund Breu, CFO und Mitglied der Geschäftsleitung, Novartis AG, Basel. (Nachfolge Thierry Lombard). Als Mitglied des Ausschusses der Zulassungsstelle (Nachfolge von Thierry Lombard): Felix M. Stählin, Vorsitzender der Geschäftsleitung, National Versicherung, Basel.
Novartis Announces the Retirement of Urs Baerlocher | Evaluate
www.evaluategroup.com
He previously reported to Urs Baerlocher. Barbara Kessler, Head of Group Tax and Insurance will report to Dr. Raymund Breu, Group CFO. "I want to thank Urs Baerlocher for his contributions in overseeing several strong global functions for Novartis . He built a solid legal and tax function, and his skills were ...
Novartis May Be the Drug Stock of Choice - Barron's
www.barrons.com
Or as Novartis Chief Financial Officer Raymund Breu tells Barrons.com, "All these elements should highlight that an investment in Novartis is attractive." Others agree. J.P. Morgan Securities upgraded Novartis last month to Overweight from Neutral. And last week, Roumell Asset Management cited Novartis ...
Novartis Merger Stance: Firm "Prefers" No Deal For At Least Two ...
pink.pharmaintelligence.informa.com
Executive Summary. Novartis would "prefer" to wait two or three years before its next large transaction so it can focus on upcoming product launches, CFO Raymund Breu told the J.P. Morgan CEO conference on building shareholder value April 26. Already Registered? Sign in to continue reading. Sign In. Thanks, we've ...
Novartis Q2 2007 Earnings Call Transcript - Nasdaq
www.nasdaq.com
Raymund Breu - CFO Richard Jarvis - IR Thomas Ebeling - CEO of Pharma Joerg Reinhardt - CEO Novartis Vaccines and Diagnostics Andreas Rummelt - CEO Sandoz Alex Gorsky - Head of North America Pharma David Epstein - CEO Novartis Oncology James Shannon - Head of Pharma Development. Analysts. Andrew ...
Novartis may nudge up bid for rest of Alcon
www.ibtimes.com
The Alcon deal could mark the swansong of two senior Novartis executives, CEO Daniel Vasella and finance chief Raymund Breu, keen to push through the transaction at more favorable terms to secure their legacy. That would echo last year's events at Novartis' Swiss rival Roche (ROG.VX), whose $47 ...
Novartis says swine flu virus gives poor harvest for vaccine - FirstWord ...
www.firstwordpharma.com
Novartis has not added this revenue to its sales outlook, noted company CFO Raymund Breu. Click here for more information and the newest developments on influenza A (H1N1). You can also follow @fwpharma on Twitter for news updates throughout the day. To read more NewsPoints articles, click here.
Novartis: Dobili bomo več kot 51 odstotkov - Medicina in ljudje - Finance
medicina.finance.si
Pričakujemo, da bomo dobili več kot 51 odstotkov, pravi finančni direktor skupine Novartis Raymund Breu. O uspešnosti ponudbe je prepričan, ker na petkovi skupščini niso bili navzoči vsi delničarji, medtem ko se bodo, ali Novartisovo ponudbo sprejmejo ali ne, odločali vsi. "Na petkovi skupščini je bilo prisotnega le 64 ...
Swiss Exchange members - Financial News
www.fnlondon.com
Jacques de Saussure (partner at Pictet & Cie), Dr Raymund Breu (chief finance officer of Novartis), Jean-Luc de Buman (senior vice-president at SGS) and Daniel Schweizer (managing director of Warburg Dillon Read) replace the following departing board members: Philippe Bertherat (director of Pictet ...
All web results to the name "Raymund Breu"
Related search requests for Raymund Breu
| Jonathan Symonds Daniel Vasella David Epstein | Michel Orsinger Georg Watzek Juha Räisänen | Richard Jarvis Jakob Baer Renato Fassbind |
People Forename "Raymund" (603) Name "Breu" (218) |
sorted by relevance / date